Repurposing Eltrombopag for Multidrug Resistant <i>Staphylococcus aureus</i> Infections
The continuous rise of antimicrobial resistance urgently demands new therapeutic agents for human health. Drug repurposing is an attractive strategy that could significantly save time delivering new antibiotics to clinics. We screened 182 US Food and Drug Administration (FDA)-approved drugs to ident...
Main Authors: | Hyunjung Lee, Jaehoan Lee, Juchan Hwang, Sinyoung Park, Namyoul Kim, Kideok Kim, Honggun Lee, David Shum, Soojin Jang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/11/1372 |
Similar Items
-
Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus
by: Pengfei She, et al.
Published: (2022-01-01) -
Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
by: Mehmet Can Uğur, et al.
Published: (2021-08-01) -
Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant
by: Hong Tian, et al.
Published: (2022-08-01) -
Successful Eltrombopag Therapy in a Child with MYH9-Related Inherited Thrombocytopenia
by: Giuseppe Lassandro, et al.
Published: (2022-11-01) -
Immune thrombocytopenia and cerebral thrombophlebitis in a patient on eltrombopag: A rare complication
by: Salma Fares, MD, et al.
Published: (2023-06-01)